Milan gives founders access to more than a concentration of investor addresses. The useful choice is between different kinds of capital: first checks for a software team, seed funding after early traction, specialist life-sciences finance, or growth capital for a technology business with a more developed operating case.
This guide compares 15 venture firms, specialist platforms and angel networks. We confirmed seven operational Milan office or base connections, then separately labelled other published Milan addresses and wider Italian or European mandates. The result is a research shortlist, not a claim that every provider is headquartered in the city or invests at the same stage.
Which venture capital firms can founders find in Milan?
P101, United Ventures, Primo, Panakès, Eureka, Sofinnova and The Techshop each publish an actual Milan base or office. Other routes below have a registered or contact address, or a wider mandate that can matter more than proximity. Use the stage and sector columns before choosing whom to research. On mobile, scroll the table sideways.
| Provider | Milan or wider connection | Stage filter | Sector fit |
|---|---|---|---|
| P101 / Prana Ventures | Milan-based | Seed to early growth; dedicated seed platform | Technology-driven companies |
| United Ventures | Milan headquarters; vehicle-specific regional mandates | Strategy-specific; UV3 Lombardia targets beyond pre-seed and seed | Technology; Lombardia parallel strategy focuses on deep tech |
| Primo Capital | Milan and Rome offices | Fund-specific; confirm the relevant entry stage | Digital, space, health and climate strategies |
| Panakès Partners | Milan and Rome offices; global investing proposition | Startup and SME life sciences; development stage varies by fund | Medical technologies and other life-science innovation |
| Eureka! Venture SGR | Milan office; fund-specific geographic conditions | Technology transfer; Z_ONE explicitly pre-seed and seed | Deep tech, science-based technology and digital strategies |
| Sofinnova Partners | Milan office within a European platform | Company creation and seed through later-stage; strategy-specific | Biopharma, medtech, digital medicine and industrial biotech |
| The Techshop | Milan office; Italy as the starting point for global growth | Seed | B2B digital products for enterprises and SMEs |
| Indaco Venture Partners | Milan contact address; Italian technology focus with wider reach | Ventures I growth-stage; biotech strategy separately defined | Digital, deep tech, medtech and pharma-biotech vehicles |
| Oltre Impact | Milan contact address; Italian impact-company strategy | Current Oltre III strategy emphasises larger, developing companies | Business models addressing social and environmental needs |
| B Heroes | Published Milan address; Italian entrepreneurs worldwide | Pre-seed and seed | Sector-agnostic |
| Italian Angels for Growth | Milan registered address; broader Italian network | Prototype and initial traction required | Life sciences, deep tech, digital and fintech |
| Italian Founders Fund | Italian-founded, Italy-expanding or Italian-founder connection | Pre-seed through Series A | Innovative companies with global ambition |
| 360 Capital | European investment mandate; no local-office assumption needed | Pre-seed through Series B | Deep tech, climate technology and digital-first solutions |
| Club degli Investitori | Italian entrepreneurship worldwide; no Milan office claimed | Portfolio spans startup to scale-up; confirm new-investment criteria | Multiple innovation sectors |
| Claris Ventures | Turin-based with international scientific reach | Company formation and preclinical through early clinical development | New medicines only |
Start with the kind of evidence your company has
- Before a mature product: investigate explicitly pre-seed routes such as B Heroes, Italian Founders Fund, 360’s relevant themes or Eureka’s Z_ONE strategy. Check the actual criteria, not only the round label.
- Seed B2B software: compare The Techshop with the appropriate P101 or Primo strategy. Prepare buyer learning, product progress and a next commercial milestone.
- A prototype with initial traction: IAG publishes those as founder-readiness requirements. A network presentation is different from a single fund’s investment committee.
- Life sciences: separate a new medicine, medical device and digital-health platform. Claris’s exclusive therapeutics mandate is not interchangeable with the broader strategies at Panakès or Sofinnova.
- More developed companies: Indaco Ventures I and the United Ventures Lombardia strategy publish maturity distinctions that can move them into a later research queue. Oltre’s current fund also emphasises larger businesses.
Keep the Italy startup-investor guide central for national coverage. This page adds Milan access, explicit company-stage comparisons and the local parallel-fund questions that broad country lists can obscure.
Fifteen investor platforms and founder routes
1. P101 / Prana Ventures
P101 describes a Milan-based strategy spanning seed to early growth, with its dedicated Prana team covering the seed stage. A founder should choose the relevant team before approaching the platform. Explain what the product has proved and what the next round makes possible. Prana, P101 and co-investment vehicles do not become three independent investors just because they have different names.
Founder route: Contact on the official P101 site; identify the seed or later-stage team. Official strategy and approach information.
2. United Ventures
United Ventures has its headquarters in Milan and a public founder proposal route. The important local detail is the vehicle: UV3 Lombardia describes deep-tech scale-ups beyond pre-seed and seed, operating in the region and co-invested alongside UV3. That is not the same proposition as a generic early-stage fund. Ask which strategy fits the company rather than assuming a Milan address clears every requirement.
Founder route: I am a Founder / Submit your proposal form. Official strategy and approach information.
3. Primo Capital
Primo separates digital, space, health and climate investing. For a software founder, the Digital strategy is more informative than the platform’s total capital: its current thesis names enterprise software, cybersecurity and fintech, alongside a broader digital-infrastructure focus. Select the relevant strategy and clarify entry-stage expectations. Its Milan office is a real connection, but the actual fund determines the investment conversation.
Founder route: Funding/contact form linked from the relevant strategy page. Official strategy and approach information.
4. Panakès Partners
Panakès combines a Milan presence with a specialist life-sciences mandate. Its current site describes investing globally in startups and innovative smaller companies solving medical needs. Prepare the scientific or product evidence, development pathway and milestone, then identify the appropriate fund. A healthcare label alone is not enough: a device, therapeutic programme and software product can require different investor expertise.
Founder route: Official fund information and published contact route. Official strategy and approach information.
5. Eureka! Venture SGR
Eureka’s current platform includes several genuinely different investment jobs. Its technology-transfer strategy connects scientific research with company building; Z_ONE, launched in 2026, explicitly targets pre-seed and seed AI applications and urban technology. BlackSheep is another fund on the manager’s platform, not an additional independent entry here. Select the fund first, especially where a strategy has a regional restriction or an acquisition focus.
Founder route: Submit form for a pitch or executive summary. Official strategy and approach information.
6. Sofinnova Partners
Sofinnova has an actual Milan office and several specialist strategies across life sciences. The Telethon strategy explicitly supports leading Italian science, while other funds cover areas such as early biopharma, medical devices, digital medicine and industrial biotechnology. Match the development programme to the strategy. Its project-submission page asks for an overview and non-confidential presentation, making the first disclosure boundary clear.
Founder route: Submit a project, including a non-confidential presentation. Official strategy and approach information.
7. The Techshop
The Techshop is a particularly clear starting point for a Milan B2B software team at seed. It describes an enterprise-and-SME software focus, an actual Milan office and Italy as the launch point for international growth. Prepare the product roadmap, buyer evidence and go-to-market learning. Use its dedicated founder contact page rather than treating the general enquiries channel as the investment process.
Founder route: Dedicated founder Get in touch page. Official strategy and approach information.
8. Indaco Venture Partners
Indaco is useful precisely because its funds should not be flattened into one early-stage label. Ventures I describes growth-stage companies with proprietary technology, while Indaco BIO has a separate therapeutic focus. Its Lombardia parallel vehicles support selected companies from the associated portfolios. A new founder should start with the manager’s project route and ask about the relevant primary vehicle, rather than pitching a parallel fund as a standalone opportunity.
Founder route: Send us your project on the official site. Official strategy and approach information.
9. Oltre Impact
Oltre connects investment with social and environmental outcomes built into the business model. Its current third-fund description places greater emphasis on larger companies with development potential, which matters for founders comparing it with pre-seed investors. Bring both the operating case and the impact mechanism. Use the entrepreneur project form, and confirm whether the company’s maturity fits the current vehicle rather than an older portfolio example.
Founder route: Sei un imprenditore? Inviaci il tuo progetto founder form. Official strategy and approach information.
10. B Heroes
B Heroes explicitly focuses on pre-seed and seed, supporting Italian entrepreneurs around the world. Its sector-agnostic approach offers a different research route from a specialist medical or climate fund. Explain the founder connection, what the team is building and why the first financing milestone matters. Its startup onboarding route is the investment starting point, not a promise that ecosystem participation produces funding.
Founder route: Apply your startup / Send pitch onboarding route. Official strategy and approach information.
11. Italian Angels for Growth
IAG’s founder criteria make readiness concrete: full-time founders, a prototype and initial traction metrics. Its member-led process can include a champion who contributes time as well as capital. That is a different route from pitching a single institutional fund. The network’s registered Milan address should not be confused with a Milan-only mandate or an operational headquarters; assess the company through its published founder requirements.
Founder route: Propose your startup form linked to Dealum. Official strategy and approach information.
12. Italian Founders Fund
Italian Founders Fund defines its connection more broadly than an Italian headquarters: companies can be founded in Italy, expand into the country or have Italian founders elsewhere. It describes leading or co-leading from pre-seed through Series A. For a Milan company, show the founder insight and global opportunity rather than relying on location alone. Use the founder form, not the manager’s investor-facing material.
Founder route: Get in touch founder form. Official strategy and approach information.
13. 360 Capital
360’s public pitch page gives three direct filters: Europe, pre-seed through Series B, and deep tech, climate tech or digital-first solutions. That makes it a useful wider-mandate comparison for an eligible Milan team. Explain the technical advantage and the specific customer or development milestone. A broad stage range does not remove the need to choose a credible entry point for this company.
Founder route: Pitch now / Submission form. Official strategy and approach information.
14. Club degli Investitori
Club degli Investitori frames its network around Italian founders and the combination of capital, expertise and useful connections. It is a wider research route, not an assumed Milan office. Its public portfolio spans different company stages, so ask what current new-investment evidence is required rather than inferring a rule from one successful company. The official homepage provides an Apply with your startup route.
Founder route: Apply with your startup button linked to Dealum. Official strategy and approach information.
15. Claris Ventures
Claris is based in Turin, but a Milan scientist can research it for a different reason: its explicit focus on new medicines from company formation and preclinical work through early clinical development. It invests in existing companies and helps create new ones around differentiated biology. Prepare experimental and translational evidence. This is not a general digital-health, wellness-app or medical-device fund.
Founder route: Scientists & founders / Start a conversation, info@clarisventures.com. Official strategy and approach information.
A Lombardia fund is not automatically a new seed route
Regional capital can be valuable, but a regional fund name does not tell you how a founder enters the process. United Ventures III Lombardia describes a parallel co-investment strategy for companies operating in Lombardy, focusing beyond pre-seed and seed. Indaco’s Lombardia vehicles describe selected companies from their associated primary-fund portfolios.
For an early founder, the next action is to identify the primary fund and ask whether the company fits. For a scale-up, prepare the operating connection and maturity evidence. Do not count the main fund, parallel vehicle and asset manager as three unrelated investors.
A worked Milan shortlist for a B2B software team
Fictional example, not a funding recommendation. Two Milan founders have a working procurement-software prototype and three paid pilot customers. The product is improving, but onboarding is still manual and the business has not demonstrated repeatable growth. They want capital to test a repeatable deployment model.
| Candidate | Why investigate | What still needs answering |
|---|---|---|
| The Techshop | Seed B2B digital focus | Does current product and buyer evidence meet its investment expectations? |
| IAG | Prototype and initial traction are published criteria | Is the pilot evidence strong enough for member sponsorship and diligence? |
| Primo Digital | B2B software is in the stated strategy | Which entry-stage and commercial requirements apply to this company? |
| UV3 Lombardia | The team operates in Lombardy | Hold this specific vehicle if the company has not reached its scale-up remit |
| Claris | No therapeutics fit | Exclude from this company’s shortlist rather than sending a generic pitch |
The exercise gives the founders three focused research conversations, one stage-related hold and one clear exclusion. It does not establish investor interest. Update the decision as the evidence changes, and keep the earlier reasoning visible.
Build your Milan investor-fit worksheet
A good shortlist connects the company’s next milestone with a specific investor strategy and a practical approach route. Copy one record per provider family.
MILAN INVESTOR FIT CARD
Company and next financing milestone: [specific evidence to produce]
Current maturity: [idea / prototype / paid pilots / repeatable revenue / growth]
Provider and exact strategy: [manager; fund or network]
Connection: [Milan office / registered address / Lombardy condition / wider mandate]
Official criteria and check date: [URL; stage; sector; geography]
Evidence we can show: [authorised facts, not projections presented as results]
Primary or parallel fund: [which route can evaluate a new company?]
Founder approach: [verified form or official business contact]
Decision: [research / clarify / approach / hold]
Relationship owner, next action and date: [person; action; date]Bring the selected providers, source links and next actions into Finta. Review relationship context, prepare a relevant introduction request or public submission, and keep the conversation connected to the evidence. Aurora can help organise the comparison and prepare the questions for your next move.
Research the shortlist with Aurora, Claude or Codex
Help me research investors for a Milan startup.
Company, founder connection and stage: [paste authorised facts]
Next financing milestone: [paste]
Candidates and current official sources: [paste]
Separate Milan operational offices, registered addresses and wider mandates.
Identify the exact fund or angel-network route for each provider.
Distinguish new-company eligibility from parallel-fund and follow-on support.
Compare sector, maturity, regional conditions and approach route.
Deduplicate related managers, fund brands, syndicates and rebrands.
Return source URL/date, fit evidence, open question, decision and next action.
Preserve missing criteria as unknown; do not invent investor interest or introductions.
Prepare a review only. Do not contact anyone or submit applications.Continue with investor prospecting, warm-introduction requests and the Seed Fundraising Comprehensive Guide. Use the European investor guide when the company’s mandate fit justifies widening the search.
Methodology and research date
By Finta Editorial Team. Official sources reviewed November 12, 2026. We refreshed provider mandates and founder routes, distinguished operational offices from registered or contact addresses, and reconciled linked manager and fund names. P101/Prana is one entry; Eureka’s managed BlackSheep and Z_ONE strategies do not create extra independent names. Platforms, angel networks and specific funds are different types of capital route, not a performance ranking.
We did not count an investment bank, incubator membership, a historic investor listing or a regionally restricted vehicle as proof that a Milan startup qualifies. Where entry stages are not explicit, the comparison leaves a concrete question rather than inferring a rule from one portfolio investment. Confirm current capacity and company-specific requirements directly.
This is general information, not personalised financial, legal or tax advice. Seek qualified advice where financing structures or regional eligibility affect company decisions. The cover’s inland canal junction and research clusters are an illustrative Milan ecosystem, not a cartographic map or a diagram of investor office locations.